Silver Book Fact

According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets late-stage metastatic melanoma. The medicine contains a gene encoding antigen that may be able to alert the immune system when there is a foreign tissue present. This would in turn induce a powerful immune response.

Categories

  • Innovative Medical Research
  • Future Value

Related Facts

  • Between 2008 and 2010, use of colonoscopy for the treatment and prevention of colon cancer saved an average of $150,364 each year, per person affected.  
  • A prostate cancer vaccine, sipleucel-T immunotherapy, in men with metastatic castration-resistant prostate cancer, reduced the risk of death by 22 percent compared to placebo, and represented a 4.2 month improvement in…  
  • According to the Pharmaceutical Research and Manufacturers of America, a medicine in development targets CA125, a surface protein, or antigen, that is released in excess quantities by some ovarian cancers.…  
  • Cancer mortality declined more than 2% in 2003, a continuation of the decline that began in 1990.  
  • If the use of recommended colorectal screening increased to 70.5 percent, 1,000 additional lives could be saved each year.